Advanced Non-Small Cell Lung Cancer (NSCLC)

Prior treatment with and failure of at least one regimen of chemotherapy and erlotinib.

Prior treatment with no more than two chemotherapy regimens, including adjuvant or combined modality treatment.

Measurable disease .

Eastern Cooperative Oncology Group (ECOG) Performance status 0-2

Tissue available for KRAS/ EGFR testing

Creatinine clearance \> 40 cc/min or serum creat \< 1.5 x ULN

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib